53 results on '"Ma, Zhenni"'
Search Results
2. Novel GNE missense variants impair de novo sialylation and cause defective angiogenesis in the developing brain in mice
3. Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models
4. Mutation detection and inhibitor analysis of 43 children with severe hemophilia A in a single center: three novel mutations
5. ETV6::ACSL6 fusion gene in myeloid malignancies with eosinophilia: a report of two cases with t(5;12) or normal karyotype
6. Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C
7. The association between serum interleukin-1 beta and heparin sulphate in diabetic nephropathy patients
8. Nonsense‐mediated mRNA decay efficiency influences bleeding severity in ITGA2B c. 2659C > T (p. Q887X ) knock‐in mice
9. From CO2 to Formic Acid Fuel Cells
10. Monocyte upregulation of podoplanin during early sepsis induces complement inhibitor release to protect liver function
11. Tryptophan 387 and 390 residues in ADAMTS13 are crucial to the ability of vascular tube formation and cell migration of endothelial cells
12. Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13
13. Thermodynamically unconstrained forced concentration cycling of methane catalytic partial oxidation over CeO2 FeCralloy catalysts
14. Feedback modulation of endothelial cells promotes epithelial‐mesenchymal transition and metastasis of osteosarcoma cells by Von Willebrand Factor release
15. von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro
16. Application of High-Throughput Sequencing in the Diagnosis of Inherited Thrombocytopenia
17. Identification of a crucial tryptophan residue in ADAMTS13 required for its secretion and enzymatic activity
18. A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13
19. A Novel Monoclonal Antibody Against A2 Domain of Von Willebrand Factor Reduces Its Proteolysis By ADAMTS13
20. A micro-refinery to reduce associated natural gas flaring
21. Pt on Fecralloy catalyses methane partial oxidation to syngas at high pressure
22. Partial oxidation of methane to syngas over Pt/Rh/MgO catalyst supported on FeCralloy woven fibre
23. Alterations of Plasma Complement C3b, C5b and VWF, ADAMTS13 in Patients with Graft-Versus-Host Disease and Thrombotic Microangiopathy after Hematopoietic Stem-Cell Transplantation
24. The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13
25. Mutations in the D1 domain of von Willebrand factor impair their propeptide-dependent multimerization, intracellular trafficking and secretion
26. Mutations in the D1 Domain Inhibit Propeptide-Dependent Multimerization, Trafficking and Regulated Secretion of Von Willebrand Factor in VWD
27. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty
28. Simvastatin Increases ADAMTS13 Expression in Podocytes
29. The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity
30. Copper-catalyzed asymmetric 1,4-conjugate addition of Grignard reagents to linear α,β,γ,δ-unsaturated ketones
31. ChemInform Abstract: Switchable Stereoselectivity: The Effects of Substituents on the D2‐Symmetric Biphenyl Backbone of Phosphoramidites in Copper‐Catalyzed Asymmetric Conjugate Addition Reactions with Triethylaluminum.
32. The W–x–x–W Motif in the TSR1 of ADAMTS13 Is Important for Its Secretion
33. The Co-Influence of VWD Type 2B and Type 2M Mutations and Platelet GPIbα On the Susceptibility of VWF to ADAMTS13 Under Shear Stress
34. Simvastatin Improve ADAMTS13 mRNA and Protein Expression in Podocytes.
35. Changes of ADAMTS13 Activity and VWF Level in the Plasma of Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
36. Switchable Stereoselectivity: The Effects of Substituents on the D2-Symmetric Biphenyl Backbone of Phosphoramidites in Copper-Catalyzed Asymmetric Conjugate Addition Reactions with Triethylaluminium
37. Identification and Functional Analysis of a Novel von Willebrand Factor Mutation in a Family with Type 2A von Willebrand Disease
38. The effects of solvent on switchable stereoselectivity: copper-catalyzed asymmetric conjugate additions using D2-symmetric biphenyl phosphoramidite ligands
39. Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease
40. ChemInform Abstract: Enantioselective Synthesis of Chiral γ‐Aryl α‐Keto Ester by Copper‐Catalyzed 1,4‐Conjugate Addition Using D2‐Symmetric Biphenyl Phosphoramidite Ligand.
41. Von Willebrand Factor, ADAMTS13 Activity, TNF-Alpha, and Their Relationships in Patients with Chronic Kidney Disease
42. Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
43. Enantioselective synthesis of chiral γ-aryl α-keto ester by copper-catalyzed 1,4-conjugate addition using D2-symmetric biphenyl phosphoramidite ligand
44. A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
45. All-Trans Retinoic Acid Modulates the Balance of ADAMTS13 and VWF In Human Microvascular Endothelial Cells
46. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro
47. Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms
48. Thrombospondin-1 and ADAMTS13 Competitive Binding with VWF Mainly in Both A2 and A3 Domain.
49. Epitope Mapping of a Monoclonal Antibody against VWF Which Diminishes the Proteolytic Cleavage of VWF by ADAMTS13 Under Flow.
50. Evaluation and Clinical Application of a New Method for Detecting ADAMTS13 Activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.